Medicare

Medicare

featured image of Medicare to Increase Reimbursement for Cell & Gene Therapy in 2025

Medicare to Increase Reimbursement for Cell & Gene Therapy in 2025

BIOT

📰 CMS proposes increasing reimbursement for cell & gene therapies for Medicare, aligning Medicaid plans for sickle cell disease. 💰 🏥 Payments for gene therapy could increase to 75 of cost. 🩺 Aim is to provide practical reimbursement strategy. 💡